Skip to main content
. 2012 Aug 27;7(8):e43976. doi: 10.1371/journal.pone.0043976

Figure 1. Serum samples from patients with GBS and from controls with other neurological disease (OND) and family controls (FC) were tested for IgG activity to lipo-oligosaccharides (LOS) from 6 C. jejuni.

Figure 1

Subcharts represent serum IgG activity to LOS from (A) C. jejuni BD-07 isolated from a GBS patient (B) C. jejuni BD-39 isolated from a GBS patient, (C) C. jejuni BD-10 isolated from a GBS/MFS patient, (D) C. jejuni BD-67 isolated from a GBS/MFS patient, (E) C. jejuni BD-94 isolated from a GBS patient (F) C. jejuni Penner HS:03 serostrain (CCUG 10937), lacking ganglioside mimics, as a control. *p<0.001. Lines () indicate cut-off value. GBS, Guillain-Barré syndrome; OND, other neurological disease; FC, family controls; LOS, lipo-oligosaccharides.